These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 1461658

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.
    Pellegata NS, Sessa F, Renault B, Bonato M, Leone BE, Solcia E, Ranzani GN.
    Cancer Res; 1994 Mar 15; 54(6):1556-60. PubMed ID: 8137263
    [Abstract] [Full Text] [Related]

  • 23. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas.
    Oda H, Nakatsuru Y, Ishikawa T.
    Cancer Res; 1995 Feb 01; 55(3):658-62. PubMed ID: 7834636
    [Abstract] [Full Text] [Related]

  • 24. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.
    Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, Ullrich S, Romano JW, Appella E, Testa JR.
    Cancer Res; 1991 Aug 01; 51(15):4090-6. PubMed ID: 1855224
    [Abstract] [Full Text] [Related]

  • 25. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
    Komuro H, Hayashi Y, Kawamura M, Hayashi K, Kaneko Y, Kamoshita S, Hanada R, Yamamoto K, Hongo T, Yamada M.
    Cancer Res; 1993 Nov 01; 53(21):5284-8. PubMed ID: 8221663
    [Abstract] [Full Text] [Related]

  • 26. p53 Mutations in human hepatocellular carcinomas from Germany.
    Kress S, Jahn UR, Buchmann A, Bannasch P, Schwarz M.
    Cancer Res; 1992 Jun 01; 52(11):3220-3. PubMed ID: 1317262
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS.
    Cancer Res; 1994 Aug 15; 54(16):4342-6. PubMed ID: 8044781
    [Abstract] [Full Text] [Related]

  • 29. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
    Stork P, Loda M, Bosari S, Wiley B, Poppenhusen K, Wolfe H.
    Oncogene; 1991 May 15; 6(5):857-62. PubMed ID: 1646989
    [Abstract] [Full Text] [Related]

  • 30. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T, Reynolds S, Maronpot R, Anderson M.
    Cancer Res; 1990 Aug 01; 50(15):4818-23. PubMed ID: 2196119
    [Abstract] [Full Text] [Related]

  • 31. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
    Chang KW, Sarraj S, Lin SC, Tsai PI, Solt D.
    Carcinogenesis; 2000 Jul 01; 21(7):1441-51. PubMed ID: 10874024
    [Abstract] [Full Text] [Related]

  • 32. Absence of p53 gene mutations in primary neuroblastomas.
    Vogan K, Bernstein M, Leclerc JM, Brisson L, Brossard J, Brodeur GM, Pelletier J, Gros P.
    Cancer Res; 1993 Nov 01; 53(21):5269-73. PubMed ID: 8221661
    [Abstract] [Full Text] [Related]

  • 33. A high frequency of N-RAS oncogene mutations in multiple myeloma.
    Tanaka K, Takechi M, Asaoku H, Dohy H, Kamada N.
    Int J Hematol; 1992 Oct 01; 56(2):119-27. PubMed ID: 1421173
    [Abstract] [Full Text] [Related]

  • 34. Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism.
    Yoshimoto K, Iwahana H, Fukuda A, Sano T, Saito S, Itakura M.
    Cancer Res; 1992 Sep 15; 52(18):5061-4. PubMed ID: 1516062
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma.
    Sameshima Y, Matsuno Y, Hirohashi S, Shimosato Y, Mizoguchi H, Sugimura T, Terada M, Yokota J.
    Oncogene; 1992 Mar 15; 7(3):451-7. PubMed ID: 1312700
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. p53 gene mutation in primary human renal cell carcinoma.
    Torigoe S, Shuin T, Kubota Y, Horikoshi T, Danenberg K, Danenberg PV.
    Oncol Res; 1992 Mar 15; 4(11-12):467-72. PubMed ID: 1299377
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.